close
  • Approved Use: Aimovig® is a prescription medicine used for the preventive treatment of migraine in adults.

You are now leaving aimovig.com

You are about to leave the aimovig.com website and enter a website operated by a third party. Amgen is not responsible for and does not endorse or control the content contained on this third-party website.

Continue

You are now leaving aimovig.com

You are about to leave the aimovig.com website and enter a website operated by a third party. Amgen & Novartis are not responsible for and do not endorse or control the content contained on this third-party website.

Continue
  1. Access to americanmigrainefoundation.org is not intended to provide medical advice or a referral to a particular physician;
  2. Patients should discuss with their physician their experience with the patient’s medical condition and should then determine if the physician is qualified to perform the procedure;
  3. Patients should discuss the risks and benefits of any procedure with their physician;
  4. americanmigrainefoundation.org is an independent entity, and not affiliated with, or an agent of, Amgen Inc.
  5. Amgen Inc. has not entered into any agreement with any doctor affiliated with americanmigrainefoundation.org to render any treatment or care to any patient, and has not evaluated the credentials, experience or expertise of any physician affiliated with, or referred through, americanmigrainefoundation.org.
  6. AMGEN INC. MAKES NO EXPRESS, IMPLIED OR STATUTORY WARRANTIES OR REPRESENTATIONS (INCLUDING THE IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE) AMERICANMIGRAINEFOUNDATION.ORG. TO THE MAXIMUM EXTENT PERMITTED BY LAW, AMGEN INC. AND ITS AFFILIATES ARE NOT RESPONSIBLE FOR AND EXPRESSLY DISCLAIM ALL LIABILITY, INCLUDING WITHOUT LIMITATION, FOR DIRECT, INDIRECT, INCIDENTAL, CONSEQUENTIAL, PUNITIVE, AND SPECIAL OR OTHER DAMAGES ARISING FROM OR RELATED TO THE USE OF ANY SERVICES OFFERED BY AMERICANMIGRAINEFOUNDATION.ORG. BY ACCESSING AMERICANMIGRAINEFOUNDATION.ORG, YOU AGREE, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW THAT YOU WILL HOLD AMGEN INC. AND ITS AFFILIATES HARMLESS FROM ANY AND ALL CLAIMS ARISING FROM OR IN CONNECTION WITH ANY ACT OR OMISSION OF AMERICANMIGRAINEFOUNDATION.ORG.

You are now leaving aimovig.com

You are about to leave the aimovig.com website and enter a website operated by a third party. Amgen Inc. is not responsible for and does not endorse or control the content contained on this third-party website.

Click “OK” to proceed or “CANCEL” to return to aimovig.com

By clicking “OK” below, you acknowledge that you have read and reviewed the information contained within the Notice of Third-Party Site at the bottom of the page.

OK CANCEL
Know Migraine Mission
Know Migraine Mission
Know Migraine Mission

The team behind Aimovig is on a mission beyond medicine.

A mission to challenge public misconceptions, start new conversations, and make the world a more migraine-friendly place. Join us and help spread the knowledge and acceptance.

KMM video

Join the Know Migraine Mission

Facebook FB logo FB logo Instagram Instagram logoInstagram logo

NOTE: U.S. residents must be logged in to Facebook on current device. If an error occurs, search “Aimovig (erenumab-aooe)” on Facebook.

The truth about migraine

18% of women and 6% of men

Migraine is more than just a headache—it’s a complex neurological disease that affects 18% of women and 6% of men in the U.S.

72
HOURS

A single migraine episode can last up to 72 hours. Nearly 50% of people with chronic migraine said they couldn’t work while experiencing migraine.

Migraine is one of the leading causes of years lived with disability, according to the Global Burden of Disease Study.

Fighting migraine can be a way of life—it is something that people may have to manage in their everyday lives, and it can keep them from doing the things they love most.

Migraine impacts people in different ways. There are a variety of symptoms that can occur—ranging from pulsating headaches and nausea to sensitivity to sound. Some people may experience only a few migraine days per month, while people with chronic migraine may be affected on many more days.

Helping all of us understand migraine better

The way migraine can be treated has changed, but the way people with migraine are treated still has a long way to go. Part of the team behind Aimovig, financed the largest survey to date of people with severe migraine, My Migraine Voice. The global, cross-sectional study aimed to understand the burden and impact of migraine directly from patients.

Migraine in the workplace

Migraine in the workplace

Amgen, part of the team behind Aimovig, is leading the charge to create a more supportive work environment for people with migraine. They’ve enacted real change in their workplace through migraine well-being initiatives focused on migraine awareness, education and management and they are working with other Fortune 500 companies to help them do the same.

Guides with tips to help you talk to your boss

Migraine at Work externalexternal Stigma at Work externalexternal

American Migraine Foundation:

Migraine at Work Guide externalexternal

The list of resources and links above is not exhaustive. These resources and links were created by independent third parties, and Amgen does not endorse any of these resources or the entities sponsoring these links.

Guides with tips
Know Migraine Mission

what you can do

The more vocal and visible we all are, the more people will recognize that this disease affects millions of us. So get involved, look for support groups in your area, join a fun run—anything to help spread the acceptance.

Join us on social and stay in the know by connecting with those living with, and impacted by, migraine.

Facebook facebook iconfacebook icon Instagram instagram iconinstagram icon

Have you been diagnosed with migraine? Are you currently pregnant? Whether or not you have taken Aimovig shortly before or during pregnancy, you may be able to share your experience through a US Pregnancy Registry to help pregnant women with migraine in the future.

Learn More instagram iconinstagram icon

Contact us here

1-833-AIMOVIG (1-833-246-6844)

8AM–9PM ET, Mon–Fri

+ +

Important Safety Information

Who should not use Aimovig®?
Do not use Aimovig if you are allergic to erenumab-aooe or any ingredients in

Who should not use Aimovig? Do not use Aimovig® if you are allergic to erenumab-aooe or any ingredients in Aimovig®. Before starting Aimovig®, tell your healthcare provider (HCP) about all your medical conditions, including if you are pregnant or plan to become pregnant, breastfeeding or plan to breastfeed.

 
–

Important Safety Information

Who should not use Aimovig®? Do not use Aimovig® if you are allergic to erenumab-aooe or any ingredients in Aimovig®. Before starting Aimovig®, tell your healthcare provider (HCP) about all your medical conditions, including if you are pregnant or plan to become pregnant, breastfeeding or plan to breastfeed. Tell your HCP about all the medicines you take, including any prescription and over-the-counter medicines, vitamins, or herbal supplements. What are possible side effects of Aimovig®? Aimovig® may cause serious side effects, including:
  • Allergic reactions. Allergic reactions, including rash or swelling can happen after receiving Aimovig®. This can happen within hours to days after using Aimovig®. Call your HCP or get emergency medical help right away if you have any of the following symptoms of an allergic reaction: swelling of the face, mouth, tongue or throat, or trouble breathing.
  • Constipation with serious complications. Severe constipation can happen after receiving Aimovig®. In some cases people have been hospitalized or needed surgery. Contact your HCP if you have severe constipation or constipation associated with symptoms such as severe or constant belly pain, vomiting, swelling of belly or bloating.
  • High blood pressure. High blood pressure or worsening of high blood pressure can happen after receiving Aimovig®. Contact your healthcare provider if you have an increase in blood pressure.
The most common side effects of Aimovig® are pain, redness, or swelling at the injection site and constipation. These are not all of the possible side effects of Aimovig®. Call your HCP for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. Click here for the full Prescribing Information and Patient Product Information.

Approved Use

Aimovig® is a prescription medicine used for the preventive treatment of migraine in adults.
References: 1. Parsabiv® (etelcalcetide) prescribing information, Amgen. 2. Data on file, Amgen; [Summary of Clinical Efficacy; 2015]. 3. Alexander ST, et al. Mol Pharmacol. 2015;88:853-865. 4. Data on file, Amgen; [Report R20130052, 2014]. 5. Chen P, et al. CPT Pharmacometrics Syst Pharmacol. 2016;5:484-494. 6. Sensipar® (cinacalcet) prescribing information, Amgen. 7. Ma JN, et al. J Pharmacol Exp Ther. 2011;337:275-284.